← All diseases
Cancer
Lung cancer (small cell)
Do you want to receive a message when there is new research about Small Cell Lung Cancer (SCLC)? This is possible with an account. Create a free account or log in.
Automatically tracked from PubMed and ClinicalTrials.gov, newest on top. Nothing ever disappears here: what you keep in your favorites remains findable. · RSS feed of this disease · only the strongest evidence
Read in plain language what each study is about? With Premium, above every publication you see one sentence explaining what was studied — and you'll be notified as soon as there is new research about Small cell lung cancer. View what Premium costs.
Publications (2657)
- Racial and Other Healthcare Disparities in Patients With Extensive-Stage SCLC. (2020/10/20) ♡
- Circulating Tumor DNA as a Biomarker of Radiographic Tumor Burden in SCLC. (2020/10/20) ♡
- Prognostic Impact of Single and Multiple Descriptors in Pathologically Staged T3N0M0 NSCLC. (2020/10/20) ♡
- Early-stage study (phase 1 or 2)iEarly research in a small group, primarily aimed at safety and dosage. Whether it actually works still needs to be determined afterward. A Phase Ib Trial of Personalized Neoantigen Therapy Plus Anti-PD-1 in Patients with Advanced Melanoma, Non-small Cell Lung Cancer, or Bladder Cancer. (2020/10/15) ♡
- Angiotensin-converting enzyme inhibitors and angiotensin II receptor blockers might be associated with lung adenocarcinoma risk: a nationwide population-based nested case-control study. (2020/10/15) ♡
- Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Japanese Lung Cancer Society Guidelines for Stage IV NSCLC With EGFR Mutations. (2020/10/12) ♡
- Kirsten rat sarcoma virus protein overexpression in adenocarcinoma lung: Association with clinicopathological and histomorphological features. (2020/10/08) ♡
- Daratumumab Plus Atezolizumab in Previously Treated Advanced or Metastatic NSCLC: Brief Report on a Randomized, Open-Label, Phase 1b/2 Study (LUC2001 JNJ-54767414). (2020/10/07) ♡
- JNJ-64041757 (JNJ-757), a Live, Attenuated, Double-Deleted Listeria monocytogenes-Based Immunotherapy in Patients With NSCLC: Results From Two Phase 1 Studies. (2020/10/05) ♡
- Fluoropyrimidin-2,4-dihydroxy-5-isopropylbenzamides as antitumor agents against CRC and NSCLC cancer cells. (2020/10/01) ♡
- HYR-2 plays an anti-lung cancer role by regulating PD-L1 and Akkermansia muciniphila. (2020/10/01) ♡
- Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. BRM270 targets cancer stem cells and augments chemo-sensitivity in cancer. (2020/10/01) ♡
- Herbal formula Renshenwuweizi decoction induces p53-mediated cell cycle arrest and apoptosis in A549 cells. (2020/10/01) ♡
- Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Therapeutic potentials of curcumin in the treatment of non-small-cell lung carcinoma. (2020/10/01) ♡
- Postoperative prognostic nutritional index as a prognostic factor after non-small cell lung cancer surgery. (2020/10/01) ♡
- Inflammatory Risk Factors for Early Recurrence of Non-Small Cell Lung Cancer Within One Year Following Curative Resection. (2020/10/01) ♡
- Nivolumab increases pulmonary artery pressure in patients treated for non-small cell lung cancer. (2020/10/01) ♡
- The prognostic value of pretreatment prognostic nutritional index in patients with small cell lung cancer and it's influencing factors: a meta-analysis of observational studies. (2020/10/01) ♡
- Pretreatment prognostic nutritional index is a prognostic marker for extensive-stage small cell lung cancer patients treated with anlotinib. (2020/10/01) ♡
- Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Primary tumor and metastasis-sectioning the different steps of the metastatic cascade. (2020/10/01) ♡
- [Does lung cancer patients' survival increase?]. (2020/10/01) ♡
- [Different histological subtypes of lung cancer, mutations and rearrangements]. (2020/10/01) ♡
- [Alkaline processing of cantharidin can significanty improve the antitumor activity of cantharidin]. (2020/09/30) ♡
- Commentary or editorialiAn expert's opinion or commentary, not new research. Radiomics: A Path Forward to Predict Immunotherapy Response in Non-Small Cell Lung Cancer. (2020/09/30) ♡
- Are patients with stage III non-small cell lung cancer treated with chemoradiotherapy at risk for cardiac events? Results from a retrospective cohort study. (2020/09/28) ♡
- [Heterogeneity of small cell lung cancer: biological and clinicopathological implications]. (2020/09/23) ♡
- Serial Plasma Cell-Free Circulating Tumor DNA Tests Identify Genomic Alterations for Early Prediction of Osimertinib Treatment Outcome in EGFR T790M-Positive NSCLC. (2020/09/19) ♡
- Control and Toxicity in Melanoma Versus Other Brain Metastases in Response to Combined Radiosurgery and PD-(L)1 Immune Checkpoint Inhibition. (2020/09/16) ♡
- Characterization of Immune Checkpoint Inhibitor-Related Cardiotoxicity in Lung Cancer Patients From a Rural Setting. (2020/09/15) ♡
- Description of individual patientsiThe story of one or a couple of patients. Informative, but you cannot infer from it whether something works in general. Hot-clot artifact in the lung parenchyma on (18)F-fluorodeoxyglucose positron emission tomography/computed tomography mimicking malignancy with a homolateral non-small cell lung cancer. (2020/09/14) ♡
- Decoding and Systematization of Medical Imaging Features of Multiple Human Malignancies. (2020/09/11) ♡
- Laboratory or animal researchiNo research in humans yet. Promising in a test tube or in mice unfortunately means nothing for patients. Baicalein suppresses vasculogenic mimicry through inhibiting RhoA/ROCK expression in lung cancer A549 cell line. (2020/09/08) ♡
- Peripheral blood markers predictive of outcome and immune-related adverse events in advanced non-small cell lung cancer treated with PD-1 inhibitors. (2020/09/01) ♡
- Predictive value of immune-inflammation indices in metabolic response and outcome after curative radiotherapy in patients with non-small cell lung cancer. (2020/09/01) ♡
- Endogenous levels of 1-O-acylceramides increase upon acidic ceramidase deficiency and decrease due to loss of Dgat1 in a tissue-dependent manner. (2020/09/01) ♡
- Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. [Surgical management of resectable non-small cell lung cancer: Towards new paradigms]. (2020/09/01) ♡
- BMP2 signalling activation enhances bone metastases of non-small cell lung cancer. (2020/09/01) ♡
- Combination of Juzentaihoto and chemotherapy improves the prognosis of patients with postoperative recurrence of non-small cell lung cancer. (2020/09/01) ♡
- Description of individual patientsiThe story of one or a couple of patients. Informative, but you cannot infer from it whether something works in general. The Medical Concrete Cancer of the Lung: A Unique Case Report. (2020/09/01) ♡
- Randomized researchiParticipants were divided into groups by lottery and compared with each other. This reduces the chance that a difference is due to something other than the treatment. Clinical trial evaluating efficacy and safety of pemetrexed based chemotherapy regimen versus ramucirumab plus erlotinib in Chinese patients with lung cancer: A preliminary investigation. (2020/09/01) ♡
- Positive Effects of Preventive Nutrition Supplement on Anticancer Radiotherapy in Lung Cancer Bearing Mice. (2020/08/28) ♡
- Panomicon: A web-based environment for interactive, visual analysis of multi-omics data. (2020/08/19) ♡
- A framework for clinical and translational research in the era of rigor and reproducibility. (2020/08/19) ♡
- Circulating Proteoglycan Endocan Mediates EGFR-Driven Progression of Non-Small Cell Lung Cancer. (2020/08/15) ♡
- Pharmacokinetic Profiles Determine Optimal Combination Treatment Schedules in Computational Models of Drug Resistance. (2020/08/15) ♡
- Clinical trialiResearch in patients, without randomization between groups. Useful, but less certain than a randomized trial. A multicenter randomized controlled trial to assess the efficacy of cancer green therapy in treatment of stage IIIb/IV non-small cell lung cancer. (2020/08/14) ♡
- Meta-analysisiAll studies on one question combined and calculated together. This is the strongest form of research that exists: a single loose study can be coincidence, dozens together much less so. The label says something about the design, not about the outcome — which can also be that something does NOT work. Combination of traditional Chinese medicine and epidermal growth factor receptor tyrosine kinase inhibitors in the treatment of non-small cell lung cancer: A systematic review and meta-analysis. (2020/08/07) ♡
- Discovery of [1,2,3]triazolo[4,5-d]pyrimidine derivatives as highly potent, selective, and cellularly active USP28 inhibitors. (2020/08/01) ♡
- Meta-analysisiAll studies on one question combined and calculated together. This is the strongest form of research that exists: a single loose study can be coincidence, dozens together much less so. The label says something about the design, not about the outcome — which can also be that something does NOT work. Efficacy of traditional Chinese Medicine combined with chemotherapy in patients with non-small cell lung cancer (NSCLC): a meta-analysis of randomized clinical trials. (2020/08/01) ♡
- Meta-analysisiAll studies on one question combined and calculated together. This is the strongest form of research that exists: a single loose study can be coincidence, dozens together much less so. The label says something about the design, not about the outcome — which can also be that something does NOT work. [Meta-analysis of Banmao Capsules in adjuvant treatment for non-small cell lung cancer]. (2020/08/01) ♡
codex.care does not provide medical advice. Always discuss symptoms, medication, and treatment choices with your own healthcare provider.